A phase 2 study of oral MKC-1, an inhibitor of importin-β,...

Investigational New Drugs 2012 / 08 Vol. 30; Iss. 4

A phase 2 study of oral MKC-1, an inhibitor of importin-β, tubulin, and the mTOR pathway in patients with unresectable or metastatic pancreatic cancer

Jason E. Faris, Jamie Arnott, Hui Zheng, David P. Ryan, Thomas A. Abrams, Lawrence S. Blaszkowsky, Jeffrey W. Clark, Peter C. Enzinger, Aram F. Hezel, Kimmie Ng, Brian M. Wolpin, Eunice L. Kwak
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
30
Language:
english
Pages:
7
DOI:
10.1007/s10637-011-9708-3
Date:
August, 2012
File:
PDF, 169 KB
english, 2012
Conversion to is in progress
Conversion to is failed